🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchPhase 3 trial enrollment guide — my results so far Page 4

Phase 3 trial enrollment guide — my results so far

josh_phd_bmore Mon, Feb 23, 2026 at 12:22 PM 21 replies 1,019 viewsPage 4 of 5
NurseLeah_Nash
Member
278
1,234
Sep 2024
Nashville, TN
Feb 27, 2026 at 2:33 PM#16

Clinical perspective, offered as context rather than as advice. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

26 1RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 23 others
Reply Quote Save Share Report
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Feb 27, 2026 at 9:35 PM#17
jason_paloalto said:
One practical note: write down what you did and when, before you need it.

This answered a question I did not know how to ask. Sending this to two other people who asked me the same thing last week.

25 0PedsEndoPhilly, SleepDoc_PDX, RegAffairsDC and 22 others
Reply Quote Save Share Report
Dr.SportsMedIN
Senior Member
1,456
6,789
Feb 2024
Indianapolis, IN
Feb 28, 2026 at 4:37 AM#18

Clinical perspective, offered as context rather than as advice. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

24 24adam_van, Dr.SurgeonPGH, rachel_ABQ and 21 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
CryptoCarl
Member
789
3,456
May 2024
Arizona
Feb 28, 2026 at 11:39 AM#19
Dr.SportsMedIN said:
It helps to say which part of this you are uncertain about.

Second this. Posting only so the count is not one.

Last edited: Feb 28, 2026 at 3:39 PM
23 23BethLabQueen, ChrisMacros, KetoKyle and 20 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Feb 28, 2026 at 6:42 PM#20

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Carry on.

Last edited: Feb 28, 2026 at 8:42 PM
1 1PurityPaulOR
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register